// App-Quantinova.ai

9030 : Pneumonitis in non-small cell lung cancer (NSCLC) patients treated with programmed death 1 (PD1) axis inhibitors.

Researchers

Presenter

  • Scott N. Gettinger

Principal Investigators

  • Xuchen Zhang

  • Robert Homer

  • Jennifer Possick

  • Anna Wurtz

  • Sarah B. Goldberg

  • Anne C. Chiang

  • Roy S. Herbst

  • Ami Rubinowitz

Medical Centers

  • Yale Comprehensive Cancer Center, New Haven, CT

  • Yale University, New Haven, CT

  • Yale University School of Medicine, New Haven, CT

  • Yale University-Yale Cancer Center, New Haven, CT

  • Yale Cancer Center, New Haven, CT

  • Yale University School of Medicine and Yale Cancer Center, New Haven, CT

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

  • Pulmonary alveolar proteinosis

  • Solid malignancies

Biomarkers

  • Programmed death-ligand 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved